Compare Cigna Corp (CI) vs JPMorgan Chase & Co (JPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs JPMorgan Chase & Co — how do they compare? Cigna Corp trades at $300.3 (market cap $80.25B), while JPMorgan Chase & Co trades at $344.56 (market cap $911.47B). The key difference: JPMorgan Chase & Co is far larger — about 11.4× Cigna Corp's market cap, and Cigna Corp pays the higher dividend (2.06%). Which is the better fit depends on your goals.
| CI | JPM | |
|---|---|---|
Market Cap | $80.25B | $911.47B |
Sector | Health | Financials |
52-Week High | $311.00 | $342.89 |
52-Week Low | $244.41 | $282.84 |
Enterprise Value | $103.35B | — |
Dividend Yield | 2.06% | 1.75% |
Volume | — | 10,479,943 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $304.50, up 3.76% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $7.79 exceeding the $7.60 estimate. Valuation metrics appear attractive with a P/E of 12.91 and P/S of 0.29. Recent news highlights strategic AI investments in pharmacy services and positive sector sentiment.
The investment case centers on undervaluation, earnings momentum, and dividend yield, though risks include regulatory challenges and moderating cash flow. With a consensus price target of $339.82 implying 11.6% upside, Wall Street maintains a bullish stance, but investors should weigh execution risks against growth initiatives.
JPMorgan Chase (JPM) trades at $334.53, down 0.58% on the day, with a bullish technical signal and strong fundamentals. Recent earnings beat expectations in Q1 and Q2 2026, with revenue growth from $181.85B in 2025 to $186.4B projected for 2026. The stock shows a P/E of 14.69 and ROE of 17.03%, supported by a 'Moderate Buy' analyst consensus and a $377.75 price target. News highlights CEO Jamie Dimon's economic warnings and upcoming Q1 earnings as key catalysts.
Outlook remains positive with earnings momentum and institutional support, but risks include geopolitical tensions, cybersecurity threats from AI, and volatile cash flows. The stock offers value with upside potential, though investors should monitor economic headwinds and interest rate impacts on banking performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →
